BFEC
CTIC

Benjamin F. Edwards & Company’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,090
Closed -$18K – 1001
2013
Q3 		$18K Buy
+1,090
New +$12.6K 0.01% 524

Other funds holding CTIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Benjamin F. Edwards & Company's CTIC Position: Q4 2013 in Review

Benjamin F. Edwards & Company sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2013, closing a stake of 1,090 shares — an estimated $18K sold.

Benjamin F. Edwards & Company first reported a position in CTIC in Q3 2013 and held it in 1 quarter. The position peaked at $18K in Q3 2013. 76 funds tracked by Wall St. Rank hold CTIC as of Q4 2013.

  • Benjamin F. Edwards & Company reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2013 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 1,090 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2013, an estimated $18K.
  • Benjamin F. Edwards & Company first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's CTI BioPharma Corp. (DE) Common Stock position peaked at $18K in Q3 2013.
  • 76 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2013.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2013, filed 15 Jan 2014.